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Abstract
Background: Taenia solium cysticercosis is an important zoonosis in many developing countries. Human neurocysticercosis
is recognised as an important cause of epilepsy in regions where the parasite occurs. However, it is largely underreported
and there is a lack of data about the disease burden. Because a body of information on human and porcine cysticercosis in
Cameroon is becoming available, the present study was undertaken to calculate the impact of this neglected zoonosis.
Methods: Both the cost and Disability Adjusted Life Year (DALY) estimations were applied. All necessary parameters were
collected and imported in R software. Different distributions were used according to the type of information available for
each of the parameters.
Findings: Based on a prevalence of epilepsy of 3.6%, the number of people with neurocysticercosis-associated epilepsy was
estimated at 50,326 (95% CR 37,299–65,924), representing 1.0% of the local population, whereas the number of pigs
diagnosed with cysticercosis was estimated at 15,961 (95% CR 12,320–20,044), which corresponds to 5.6% of the local pig
population. The total annual costs due to T. solium cysticercosis in West Cameroon were estimated at 10,255,202 Euro (95%
CR 6,889,048–14,754,044), of which 4.7% were due to losses in pig husbandry and 95.3% to direct and indirect losses caused
by human cysticercosis. The monetary burden per case of cysticercosis amounts to 194 Euro (95% CR 147–253). The average
number of DALYs lost was 9.0 per thousand persons per year (95% CR 2.8–20.4).
Interpretation: This study provides an estimation of the costs due to T. solium cysticercosis using country-specific
parameters and including the human as well as the animal burden of the zoonotic disease. A comparison with a study in
South Africa indicates that the cost of inactivity, influenced by salaries, plays a predominant role in the monetary burden of
T. solium cysticercosis. Therefore, knowing the salary levels and the prevalence of the disease might allow a rapid indication
of the total cost of T. solium cysticercosis in a country. Ascertaining this finding with additional studies in cysticercosis-
endemic countries could eventually allow the estimation of the global disease burden of cysticercosis. The estimated
number of DALYs lost due to the disease was higher than estimates already available for some other neglected tropical
diseases. The total estimated cost and number of DALYs lost probably underestimate the real values because the
estimations have been based on epilepsy as the only symptom of cysticercosis.
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Introduction
Taenia solium cysticercosis is an important but neglected zoonotic
disease of man and pigs in many developing countries. Human
cysticercosis is an under-recognised disease due to the large variety
of clinical symptoms, epilepsy being recognised as the most
important one, and the unavailability of appropriate diagnostic
tools in endemic areas [1]. Similarly, porcine cysticercosis is under-
reported due the absence of clinical symptoms in affected pigs and
due to the poorly functioning meat inspection services in many
endemic countries. Consequently, there is a lack of reliable data on
the disease burden of cysticercosis. Although a proper assessment
of the global burden of T. solium cysticercosis is essential, there has
been so far a limited number of studies estimating the impact of
this disease in endemic countries [2,3]. The large amount of data
available on porcine and human cysticercosis in the West of
Cameroon (which can be considered as an endemic country) [4],
allows a study of its public health and economic relevance and
consequently a better estimate of the burden of T. solium
cysticercosis which is highly needed [5]. To this end and as
already achieved for other neglected diseases [6,7], two approach-
es are considered namely the cost and the Disability Adjusted Life
Year (DALY) estimations. A comparison with previous studies
may provide indications on key factors in the more global burden
of T. solium cysticercosis.
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Study area
West Cameroon comprises three provinces (West, South-West
and North-West) with a population of about five million
inhabitants [8]. Together with the north of Cameroon the western
provinces are the main pig breeding regions of the country. Pig
husbandry is still very traditional. Human defecation occurs quite
often in the pigsties, so that many pigs have access to human faeces
[9–11]. All conditions are present for an easy transmission of T.
solium from man to pigs and vice versa [9,12]. Slaughtering of pigs
usually occurs at home or on marketplaces with limited or no
veterinary supervision. Tongue inspection is commonly carried out
to detect cases of cysticercosis. Although there is a good network of
private and public health centres in the region, the number of
neurologists, neurosurgeons and psychiatrists in Cameroon is very
small (8 for the whole country, nobody in West Cameroon) [13].
Imaging equipment for the diagnosis of epilepsy and neurocysti-
cercosis (NCC) is virtually lacking. No single CT-scan or MRI is
available in the whole study area. There is no public medical
insurance in Cameroon and only a small number of more wealthy
people have access to private insurance [14].
Parameters for the cost estimation
The epidemiological and economic parameters used in the cost
estimation are summarised in Tables 1 and 2, respectively.
A decision tree was constructed in order to identify the
proportion of the population with epilepsy due to NCC, with or
without injury, with or without treatment by a medical doctor or a
traditional healer (Figure 1). Since there were no recent reliable
figures available for the prevalence of epilepsy in Cameroon three
scenarios were used. The first one was based on a study of
Dongmo et al. (2000) [15] in which a prevalence of epilepsy of
5.8% was found based on a door-to-door survey of 1900
inhabitants of the village of Bilomo (near to Yaounde). Although
this figure is probably biased due to the high level of familial
epilepsy in that village, it is similar to the figure of 7.0% observed
in 1989 by Nkwi&Ndonko in another small village (Maham) in
West Cameroon [16]. In the second scenario we used the median
prevalence of epilepsy (1.5%) found in a meta-analysis of 28 door-
to-door studies in sub-Saharan Africa [17]. The third scenario
used a prevalence of 3.6% (in between the extremes of 5.8 and
1.5%). These scenarios agree with epilepsy prevalence figures from
Central Province of Cameroon [18].
For the estimation of the losses due to porcine cysticercosis
recent prevalence figures (4.4–6.1%) based on tongue inspection
were used [9,10] because this is the only technique applied to
detect the disease in pigs in the area. Since reliable information
about the number of pigs was not available the pig population in
West Cameroon was estimated at 285,606 based on the average of
the following two figures: (1) 450,000 being one third of the FAO
estimate of the total pig population of the country [19] (the other
2/3 of the pigs are present in North Cameroon) and (2) 121,211
being the number of pigs estimated by the ‘Projet Porc’ in West
Cameroon (Bourdanne, pers comm., 2007). For the estimation of
the pig losses it was assumed that the number of pigs slaughtered
per year is the same as the total pig population. This is based on
the fact that in traditional pig husbandry a similar number of pigs
as the number present at the beginning of the year is slaughtered
during the course of one year [20]. In Cameroon the average
reduction of the price of a cysticercosis infected animal is estimated
at 30% [21]. This is the only economic loss which has been taken
into account because, to our knowledge, porcine cysticercosis has
not been associated with clinical symptoms and consequently does
not impact on productivity [22]. The following assumptions were
made. The number of working days per year was estimated at
minimum 220 and maximum 313 in order to take into account
differences according to the economic or the informal sector. The
price of a visit to a traditional healer is difficult to estimate because
the healers usually ask an all-inclusive price until complete cure
[14]. Assuming that there are on average 10 visits, the total price
(100,000–120,000 F CFA or approximately 150 to 180 Euros) has
been divided by ten.
Parameters for the DALY estimation
The epidemiological and DALY parameters are summarised in
Table 3.
DALY estimation results from the sum of the number of years of
life lost due to mortality (YLL) and the number of years lived with
a disability (YLD) [23,24]. YLL is calculated by accumulation over
age strata of the product of the number of deaths due to the
disease and the standard life expectancy at the age of death due to
that disease. We have assumed that mortality affects the
population in a random fashion and derive the life expectancy
from the standard life table as proposed by Murray and Lopez
[23]. This table is based on the highest observed national life
expectancy (for Japanese women), but takes into account different
life expectancy between men and women. YLD is calculated by
accumulation over age strata of the product of the number of
incident cases and its severity.
The formulas for the YLL and YLD calculations are described
below:
YLL~N|L
where N is the number of deaths per year and L is the standard life
expectancy at age of death in year
YLD~I|DW|L
where I is the number of incident cases per year, DW is the
disability weight and L the average duration of the disease until
remission or death in year.
Three percent discounting and non-uniform age weighting were
used as described by Murray and Lopez [23].
Author Summary
Taenia solium cysticercosis is a zoonotic disease occurring
in many developing countries. A relatively high prevalence
in humans and pigs has been reported in several parts of
the world, but insufficient data are available on the disease
burden. Disease impact assessment needs detailed infor-
mation on well-defined epidemiological and economic
parameters. Our work conducted in West Cameroon over
several years allowed us to collect the necessary informa-
tion to estimate the impact of the parasite on the human
and animal populations in this area using both cost and
Disability Adjusted Life Year (DALY) estimations. This study
identified the professional inactivity caused by the disease
as the major loss factor in comparison to the cost of health
care and losses due to infected pigs. These findings should
allow a simpler estimation of the global disease burden
based on information on salary levels and human
cysticercosis prevalence in endemic areas of the world. In
addition, the number of DALYs lost was higher than
estimates already available for some other neglected
tropical diseases in sub-Saharan Africa.
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neurocysticercosis is not known in the area but expected to be low,
this parameter was estimated using the prevalence of epilepsy
associated with NCC described above divided by the duration of
the disease for each age category [23,25]. Therefore both
incidence rate and disease duration were assumed to be constant.
The three aforementioned prevalence scenarios were considered.
The Global Burden of Disease 1990 disability weights for epilepsy
were used in this study taking into account a difference between
treated and untreated individuals [23,26].
Cost and DALY estimations
The R software (R Development Core Team, version 2.5.0) was
used to estimate the annual socio-economic costs and number of
DALYs lost due to T. solium cysticercosis [27,28]. R allows to use
Monte Carlo simulations and allows calculating 95% confidence
regions (CR) [29]. The number of iterations was varied from 1 to
200,000 in order to achieve the optimal number. Different
distributions were used according to the type of information
available for each of the parameters (see Tables 1, 2 and 3 for
details).




The estimated number of people with NCC-associated epilepsy
and of pigs infected with cysticercosis is shown in Table 4. From
20,000 iterations onwards the cost by NCC case did not change by
Table 1. Epidemiological parameters used to calculate the disease burden of T. solium cysticercosis in West Cameroon.
ID Parameter Distribution
Value or range of
values Reference number
1 Population of the study zone Fixed 5,065,382 [8]
2 Prevalence of epilepsy (%) (1) Beta (28,1791) (1) 1.5 (1.2–1.8) [15,17,18]; see text for details
(2) Beta (67,1791) (2) 3.6 (2.8–4.4)
(3) Beta (111, 1791) (3) 5.8 (4.8–6.9)
3 Proportion of epilepsy associated with NCC (%) Uniform (0.236,0.315) 27.4
* (23.6–31.5) [34]
4 Prevalence of porcine cysticercosis (%) Beta (61,1031) - West: 6.1 [9,10]
- N-West: 4.4
5 People with epilepsy and with injury referred to the hospital (%) Beta (58,458) 11.3 [34]
6 People with epilepsy consulting only a traditional healer (%) Multinomial 11.1 [35]
7 People with epilepsy consulting only a medical doctor (%). Multinomial 44.1 [35]
8 People with epilepsy consulting both a doctor and a traditional healer (%). Multinomial 22.2 [35]
9 People with epilepsy receiving no treatment (%) Multinomial 22.6 [35]
10 Number of visits to a doctor in case of epilepsy (per year) Gamma (12,2) Min.: 1 NND**
Probable: 6
Max.: 12
11 Length of stay in a hospital (days per year) Uniform (6.5,14.5) Min.: 7 [3]
Max.: 14
12 People with epilepsy prescribed pheno-barbitone (PB) (%) Multinomial 78.7 [35]
13 People with epilepsy prescribed carbama-zepin (CBZ) (%) Multinomial 5.0 [35]
14 People with epilepsy prescribed phenytoin (PHT) (%) Multinomial 15.0 [35]
15 People with epilepsy prescribed valproate (%) Multinomial 1.3 [35]
16 Degree of compliance (%) Fixed 38.2 [35]
17 Loss of working time due to epilepsy (days per year) Gamma (2,0.2) 10.2618.7 [36]
18 Unemployed due to epilepsy (%) Fixed 21.3 [35]
19 % of the population Fixed [8]
- economically active 63.2
- not economically active 29.6
- unemployed 7.2
20 Working days per year Uniform (220,313) Min.: 220 Assumption
Max.: 313
21 Pig population in the study area Fixed 450,000 [19], Bourdanne (pers. comm.)
121,211
Average: 285,606
*figure based on results of Ag-ELISA and Ab-ELISA. However, the latter figure was decreased by 40% because of the possible presence of transient antibodies [37].
**author (NND: Nsame Nforninwe Denis).
doi:10.1371/journal.pntd.0000406.t001
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appreciably if the number of iterations would have been larger.
The estimated direct and indirect annual costs due to T. solium
cysticercosis in man and pigs are summarised in Table 5.
The economic losses due to the reduction of the value of pigs
infected with cysticercosis amount to 4.7% of the total cost of the
disease whereas the direct and indirect costs due to human
cysticercosis (NCC) add up to 95.3%. Based on a prevalence of
epilepsy of 1.5 or 5.8%, the estimated number of people with
NCC-associated epilepsy is 21,483 and 81,724, respectively. In the
former case the total cost is 4,649,104 whereas in the latter case it
amounts to 16,331,449 Euro.
DALY estimation
The estimated annual number of deaths due to NCC-associated
epilepsy and annual number of incident cases are summarised in
Table 6. The estimated annual number of DALYs lost is described
in Table 7. From 20,000 iterations onwards the number of DALYs
by thousand individuals did not change by more than 1%. This
indicates that the results would not improve appreciably if the
number of iterations would have been larger.
Discussion
Carabin and colleagues were the first to make available a
comprehensive estimation of the economic impact of cysticercosis
[3]. These authors recognise some possible improvements, one of
them being the use of context specific parameters. These were not
all available in the Eastern Cape province of South Africa and
some parameters had to be derived from studies conducted outside
Africa. Most of the data which were used in the cost estimation of
T. solium cysticercosis in this paper were specific for (West)-
Cameroon or sub-Saharan Africa or were based on the expert
opinion of some of the Cameroonian co-authors (NND, ZA).
Importantly, both the animal and human burden of this zoonotic
disease were included in the estimations.
Table 8 summarizes a comparison of the estimations of the
disease burden due to T. solium cysticercosis in West Cameroon
with the ones in the Eastern Cape Province of South Africa [3].
Although the number of NCC-associated cases of epilepsy is
higher in Cameroon, the overall monetary burden in Cameroon
(10.3 million Euro) is below the lower estimate of South Africa.
The reason for this discrepancy seems to be the lower salaries in
Cameroon. Indeed, inserting the salary parameters of Carabin et
al. in our model resulted in very similar cost estimations in
Cameroon compared to the Eastern Cape [3]. This observation
together with the elevated contribution of inactivity in the total
cost is an indication that the salaries in a country might be useful
as an indicator of the economic impact of cysticercosis per patient.
Ascertaining if knowledge on salaries and cysticercosis prevalence
is sufficiently adequate to provide an initial estimation of the total
cost of cysticercosis in other countries, would allow an extension
towards a rapid initial estimation of the global cost of cysticercosis.
Furthermore, it might be appealing to know whether or not this
observation might be extendable to other chronic endemic diseases
than cysticercosis.
It has to be noticed that the health care system in South Africa is
better organised than in Cameroon. In South Africa a relatively
good working system of medical insurance exists, which totally
lacks in Cameroon. This is illustrated by the total expenditure on
health care per capita in Cameroon which amounts to 83 Intl $
(representing 5.2% of the Gross Domestic Product, 2004) whereas
this reaches 748 Intl $ in South Africa (8.6% of the GDP, 2004)
[30]. Although expensive cerebral CT scans were for instance
carried out for a proportion of the South African people with
NCC-associated epilepsy whereas this was not the case in
Cameroon, this was not influential on the total cost differences
between the two regions [3].
In addition, this paper evaluated for the fist time the burden of
T. solium cysticercosis by estimating the number of DALYs lost due
to the disease. The average annual number of DALYs lost due to
T. solium cysticercosis in West Cameroon amounted to 9.0 per
thousand persons which is about 4 times higher than the same
Table 2. Economic parameters used to calculate the monetary burden of T. solium cysticercosis in West Cameroon.
ID Parameter Distribution Value (Euro) References
1 Cost of a visit to a physician (public hospital). Gamma (0.5,0.5) Min.: 0 NND*
Probable: 1
Max.: 5
2 Cost of a traditional healer Uniform (150,180) Min.: 150 [14]
Max.: 180
3 Cost of one day at the hospital Gamma (20,2) Min.: 5 NND*
Probable: 10
Max.: 20
4 Carbamazepin (price of treatment/day) Fixed 0.030 PMP*
5 Phenobarbitone (price of treatment/day) Fixed 0.0075 PMP*
6 Phenytoin sodium (price of treatment/day) Fixed 0.0225 PMP*
7 Valproate (price of treatment/day) Fixed 0.0225 PMP*
8 Monthly salary Uniform (75,105) Min.: 75 ZA*
Max.: 105
9 Average value of an adult pig Fixed 100 ZA*
10 Reduction (30%) of the price of the pigs diagnosed with cysticercosis Fixed 30 [21]
*co-authors (NND: Nsame Nforninwe Denis; PMP: P.M. Preux; ZA: Zoli Andre ´).
doi:10.1371/journal.pntd.0000406.t002
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miasis in sub-Saharan Africa [31].
Our study shows some limitations. The total estimated cost of
10,255,202 Euro and the total number of DALYs lost of 45838
probably underestimate the real values because the estimations
have been based on epilepsy as the only symptom of neurocys-
ticercosis. Other symptoms like chronic headache, hydrocephalus,
encephalitis, ocular cysticercosis have not been taken into account
Figure 1. Decision tree for estimating the monetary burden of neurocysticercosis (NCC) in West Cameroon (4 terminal nodes are
indicated by rectangles with bold lines).
doi:10.1371/journal.pntd.0000406.g001
The Disease Burden of Taenia solium Cysticercosis
www.plosntds.org 5 March 2009 | Volume 3 | Issue 3 | e406Table 3. DALY parameters used to calculate the disease burden of T. solium cysticercosis in West Cameroon.
ID Parameter Distribution Value References
1 People with epilepsy dying of epilepsy per year (%) Beta (3.2,124.8) 2.5 (0.7,5.6) [38]
2 Epilepsy Disability Weight for people between 0 and 4 years old not receiving
an appropriate treatment*
Beta (3,27.3) 0.099 (0.021,0.225) [23]
3 Epilepsy Disability Weight for people older than 5 years old not receiving an
appropriate treatment*
Beta (3,17) 0.15 (0.033,0.331) [23]
4 Epilepsy Disability Weight for people between 0 and 4 years old receiving an
appropriate treatment*
Beta (1.5,35) 0.041 (0.003,0.124) [23]
5 Epilepsy Disability Weight for people older than 5 years old receiving an
appropriate treatment*
Beta (1.5,21.6) 0.065 (0.004,0.192) [23]
6 Average duration of disability in males between 0 and 4 years old (years) Fixed 1.4 [23]
7 Average duration of disability in males between 5 and 14 years old (years) Fixed 2.0 [23]
8 Average duration of disability in males between 15 and 44 years old (years) Fixed 3.6 [23]
9 Average duration of disability in males between 45 and 59 years old (years) Fixed 2.8 [23]
10 Average duration of disability in males older than 60 years (years) Fixed 1.6 [23]
11 Average duration of disability in females between 0 and 4 years old (years) Fixed 1.6 [23]
12 Average duration of disability in females between 5 and 14 years old (years) Fixed 3.1 [23]
13 Average duration of disability in females between 15 and 44 years old (years) Fixed 5.9 [23]
14 Average duration of disability in females between 45 and 59 years old (years) Fixed 6.0 [23]
15 Average duration of disability in females older than 60 years (years) Fixed 2.8 [23]
*since no variability of these weights was available, beta distributions were arbitrarily used for each disability weight.
doi:10.1371/journal.pntd.0000406.t003
Table 4. Estimated number of people with NCC-associated





N People with NCC-associated
epilepsy*
50,326** 1.0 37,299–65,924
N Pigs with cysticercosis 15,961 5.6 12,320–20,044
*based on a prevalence of epilepsy of 3.6%. With a prevalence of 1.5 or 5.8% the
numbers are 21,483 and 81,724, respectively.
**of whom 10,076 did not receive any medical treatment.
uconfidence region.
doi:10.1371/journal.pntd.0000406.t004
Table 5. Estimated direct and indirect annual costs due to T.
solium cysticercosis in man* and pigs in West Cameroon.
Type of costs Value (Euro) 95% CRu % of total cost
N Hospital 595,576 312,117–1,004,400 5.8
N Medical doctor 179,001 185–968,851 1.7
N Healer 245,511 177,444–328,063 2.4
N Inactivity 8,701,883 5,600,388–12,907,812 84.9
N Drugs 54,386 40,230–71,315 0.5
N Pig losses 478,844 369,587–601,325 4.7
N Total 10,255,202 6,889,048–
14,754,044
100.0
Cost by NCC case** 194 147–253 -
*based on a prevalence of epilepsy of 3.6%.
**pig losses not taken into account.
uconfidence region.
doi:10.1371/journal.pntd.0000406.t005
Table 6. Estimated annual number of death due to NCC-
associated epilepsy and annual incident cases of epilepsy due
to NCC.
Estimate Number 95% CRu
N Annual number of deaths due to
NCC-associated epilepsy*
1258 264–3073
N Annual number of incident cases
of NCC-associated epilepsy**
18268 13458–23826
*based on a prevalence of epilepsy of 3.6%. With a prevalence of 1.5 or 5.8% the
numbers are 537 and 2024, respectively.
**based on a prevalence of epilepsy of 3.6%. With a prevalence of 1.5 or 5.8%
the numbers are 7779 and 29440, respectively.
uconfidence region.
doi:10.1371/journal.pntd.0000406.t006
Table 7. Estimated annual number of DALYs lost due to NCC-






N YLLs* 39017.0 8195.6–95512.8 85.1
N YLDs* 6821.4 2765.1–12878.4 14.9




*based on a prevalence of epilepsy of 3.6%.
**based on a prevalence of epilepsy of 3.6%. With a prevalence of 1.5 or 5.8%
the numbers are 19425.4 and 73188.7, respectively.
***based on a prevalence of epilepsy of 3.6%. With a prevalence of 1.5 or 5.8%
the numbers are 3.8 and 14.4, respectively.
uconfidence region.
doi:10.1371/journal.pntd.0000406.t007
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which seems to be very common in Africa, has also consequences
which are difficult to capture. On the other hand, the proportion
of epilepsy associated with NCC used is this study was based on
serological results which were not confirmed using imaging and
electroencephalogram. This could result in either an over- or
underestimation of our results. Moreover, because estimates of the
incidence of NCC-associated epilepsy were not available, the
number of incident cases used in this study has been estimated
using prevalence and epilepsy duration estimates. The latter are
based on overall duration of epilepsy [23] underlining the lack of
disease-specific information currently available, especially longitu-
dinal epidemiological and clinical data.
Concerning porcine cysticercosis, the monetary losses were
estimated using prevalence figures (4.4–6.1%) based on tongue
inspection. It is known that the sensitivity of this technique is only
21% [33]. Therefore, losses due to porcine cysticercosis would be
higher if better diagnostic tools would be available during meat
inspection.
In conclusion, this study shows for the first time the impact of T.
solium cysticercosis, which is a truly neglected disease in West
Cameroon. The very large proportion of the overall costs
attributable to inactivity as well as the uncertainty related to the
other parameters calls for more extensive studies to be conducted
in sub-Saharan Africa to increase the precision of these estimates.
If similar studies could be carried out in a selection of other
endemic countries in different parts of the world, it might be
possible to understand if it is possible to extrapolate the
predominant contribution of inactivity in the cysticercosis cost.
This would eventually allow calculating the global disease burden
for cysticercosis.
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